Two years ago, New York leaders required drug companies to get serious about negotiating lower prices with the state. Drug makers that didn’t agree to bigger discounts could be revealed publicly and required to disclose price information.
New York’s Medicaid program has saved more than $85 million on prescription drugs since the policy was implemented — a savings that Massachusetts is now trying to replicate with its own new drug-pricing rules, approved this summer as part of the state budget.
